Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Total income (before exceptional items) | 1,812† | 1,786† | — | — |
| Net profit | 176 | 257 | 201 | 172 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Hetal Gogri Gala | Executive Director | June 30, 2026 |
| Narendra Jagannath Salvi | Executive Director | June 30, 2026 |
| Bhavesh Rasiklal Vora | Independent Director | June 30, 2026 |
| Jeenal Kenil Savla | Independent Director | June 30, 2026 |
| Pradeep Hari Thakur | Independent Director | June 30, 2026 |
| Rupal Anand Vora | Independent Director | June 30, 2026 |
| Vilas Gajanan Gaikar | Independent Director | June 30, 2026 |
| Vinay Gopal Nayak | Independent Director | June 30, 2026 |
| Nehal Garewal | Non-Executive Director | June 30, 2026 |
| Parimal Hasmukhlal Desai | Non-Executive Director | June 30, 2026 |
| Rajendra Vallabhaji Gogri | Non-Executive Director | June 30, 2026 |
| Rashesh Chandrakant Gogri | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
